China SXT Pharmaceuticals Inc
NASDAQ:SXTC

Watchlist Manager
China SXT Pharmaceuticals Inc Logo
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Watchlist
Price: 1.741 USD 8.81% Market Closed
Market Cap: 202m USD

Gross Margin
China SXT Pharmaceuticals Inc

21.1%
Current
31%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.1%
=
Gross Profit
367.4k
/
Revenue
1.7m

Gross Margin Across Competitors

No Stocks Found

China SXT Pharmaceuticals Inc
Glance View

Market Cap
202m USD
Industry
Pharmaceuticals

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

SXTC Intrinsic Value
HIDDEN
Show
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.1%
=
Gross Profit
367.4k
/
Revenue
1.7m
What is the Gross Margin of China SXT Pharmaceuticals Inc?

Based on China SXT Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 21.1%.

Back to Top